Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of gonadotropin administration for spermatogenesis induction in hypogonadotropic hypogonadism: a possible role of androgen receptor CAG repeat polymorphism and therapeutic measures.
Giagulli VA, Triggiani V, Corona G, Carbone MD, Tafaro E, Licchelli B, Resta F, Sabbà C, Maggi M, Guastamacchia E. Giagulli VA, et al. Among authors: sabba c. Endocr Metab Immune Disord Drug Targets. 2012 Sep;12(3):236-42. doi: 10.2174/187153012802002866. Endocr Metab Immune Disord Drug Targets. 2012. PMID: 22385118 Clinical Trial.
Rendu-Osler-Weber disease: experience with 56 patients.
Sabbà C, Pasculli G, Cirulli A, Gallitelli M, Virgilio G, Guastamacchia E, Resta F, Palasciano G. Sabbà C, et al. Ann Ital Med Int. 2002 Jul-Sep;17(3):173-9. Ann Ital Med Int. 2002. PMID: 12402665
Breast cancer: biological characteristics in postmenopausal type 2 diabetic women. Identification of therapeutic targets.
Guastamacchia E, Resta F, Mangia A, Schittulli F, Ciampolillo A, Triggiani V, Licchelli B, Paradiso A, Sabbà C, Tafaro E. Guastamacchia E, et al. Among authors: sabba c. Curr Drug Targets Immune Endocr Metabol Disord. 2003 Sep;3(3):205-9. doi: 10.2174/1568008033340199. Curr Drug Targets Immune Endocr Metabol Disord. 2003. PMID: 12871027
Evidence for a putative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer: role of hormones, growth factors and specific receptors.
Guastamacchia E, Resta F, Triggiani V, Liso A, Licchelli B, Ghiyasaldin S, Sabbà C, Tafaro E. Guastamacchia E, et al. Among authors: sabba c. Curr Drug Targets Immune Endocr Metabol Disord. 2004 Mar;4(1):59-66. doi: 10.2174/1568008043339965. Curr Drug Targets Immune Endocr Metabol Disord. 2004. PMID: 15032627 Review.
319 results